Stablishment of Prevention and Treatment System for Intestinal Dysfunction
Phase 1
- Conditions
- Bowel Dysfunction
- Interventions
- Drug: Nutritional Therapy, Metabolic Disorder, Regular
- Registration Number
- NCT04507945
- Lead Sponsor
- Nanjing University School of Medicine
- Brief Summary
Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- The Patients with chronic bowel dysfunction
Exclusion Criteria
- Past severe underlying diseases of the respiratory system and cardiovascular system,
- Allergy to treatment-related drugs,
- Pregnancy,
- Accept CID surgery.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description living quality Nutritional Therapy, Metabolic Disorder, Regular - complication Nutritional Therapy, Metabolic Disorder, Regular -
- Primary Outcome Measures
Name Time Method nutrition index 3 years
- Secondary Outcome Measures
Name Time Method